June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it

was unaware the Dexcom ( DXCM ) glucose sensors it bought from

licensed distributors had been slated for destruction, after the

device maker warned some units were stolen during disposal and

resold.

Here are some details:

* Dexcom ( DXCM ) warned users in May that two lots of its G7

continuous glucose monitoring sensors were stolen during a

destruction process and later sold by third parties, with the

company tracing some of those sales to Pharmsource.

* Brunswick, Georgia-based Pharmsource said it had

immediately conducted a thorough audit of its inventory and

implemented remedial measures.

* "Pharmsource had zero involvement in Dexcom's ( DXCM ) destruction

process, which is where Dexcom ( DXCM ) reports the theft occurred," a

company spokesperson told Reuters, adding it would assist

authorities in their investigation.

* Dexcom ( DXCM ) had said one of the affected lots may carry an

increased risk of skin infection, while the other has a higher

likelihood of producing no readings.

* The device maker did not immediately respond to a request

for comment on the Pharmsource statement outside business hours.